MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    The prevalence of ICBs in patients treated with apomorphine infusion: a retrospective analysis

    P. Barbosa, A. Lees, A. Djamshidian, T. Warner (Innsbruck, Austria)

    Objective: To assess the prevalence of impulsive compulsive behaviours (ICBs) in Parkinson’s disease who donated their brains and used apomorphine infusion in life. Background: Impulsive…
  • 2019 International Congress

    Vertebral pain and bone mineral density in women with Parkinson’s disease

    I. Karaban, V. Povoroznyuk, M. Bystrytska, N. Karasevich, N. Grygorieva (Kyiv, Ukraine)

    Objective: This research aimed to study the bone mineral density (BMD) and vertebral pain in females with Parkinson’s disease (PD). Background: PD and systemic osteoporosis…
  • 2019 International Congress

    The SUNRISE-PD Study, a clinical trial of AXO-LENTI-PD: a CNS-directed gene therapy for the treatment of Parkinson’s Disease

    G. Corcoran, P. Korner, J. Wright, Y. Mo, J. Benoit, K. Binley, J. Miskin, N. Tuckwell, D. Zamoryakhin, T. Foltynie, R. Barker, K. Mitrophanous, S. Palfi (New York, NY, USA)

    Objective: This presentation will provide an overview of the design and key objectives of the SUNRISE-PD study. Background: Parkinson’s disease (PD) is caused in part,…
  • 2019 International Congress

    Real-life gait performance as a marker for motor fluctuations: the Parkinson@home Validation study

    L. Evers, J. Raykov, R. Badawy, K. Claes, M. Meinders, J. Krijthe, T. Heskes, M. Little, B. Bloem (Nijmegen, Netherlands)

    Objective: To assess the feasibility of using real-life gait performance derived from a single wearable as a marker for motor fluctuations in Parkinson’s disease (PD).…
  • 2019 International Congress

    Serum mucosal chemokine levels in patients with Parkinson disease.

    S. Haji, W. Sako, N. Murakami, Y. Osaki, Y. Izumi (Tokushima, Japan)

    Objective: To investigate the relationship between mucosal chemokines including CXCL14 and CCL28) and impairment in motor/non-motor function among patients with Parkinson’s disease. Background: Parkinson disease…
  • 2019 International Congress

    Skin in the game: Small fiber neuropathy in Parkinson’s disease and atypical parkinsonisms.

    R. Infante, G. Rizzo, A. Incensi, C. Scaglione, S. Capellari, V. Donadio, R. Liguori (Bologna, Italy)

    Objective: The aim of our study was to compare somatic and autonomic small fiber density, through skin biopsy, in Parkinson's disease (PD) and atypical parkinsonisms…
  • 2019 International Congress

    A case of osmotic demyelination syndrome presenting parkinsonism affected by blood alcohol concentration change

    M. Kondo, A. Unaki, T. Kimura (Tokyo, Japan)

    Objective: To describe a patient with osmotic myelinolysis caused by change in blood alcohol level who developed acute parkinsonism. Background: Osmotic myelinolysis is an acute,…
  • 2019 International Congress

    STN-DBS programing for dyskinesia: a case report

    L. Li, Y. Zhang (Beijing, China)

    Objective: To investigate the effect of STN stimulation on different types of dyskinesia and programming strategy. Background: Long-term use of levodopa or dopamine agonists often…
  • 2019 International Congress

    The long-term effect of continuous apomorphine treatment on camptocormia in Parkinson´s disease: a 24-months longitudinal open, prospective follow-up study

    K. Mensikova, M. Kaiserova, M. Vastik, M. Nevrly, S. Kurcova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: The aim of the study was to assess the long-term effect of subcutaneous infusions of apomorphine in the treatment of camptocormia in advanced Parkinson's…
  • 2019 International Congress

    Parkinsonian syndrome associated to C9orf72 expansion

    S. Novo Ponte, E. Gamo González, P. Sánchez Alonso (Majadahonda, Spain)

    Objective: To describe a case of parkinsonian syndrome associated to C9Orf72 expansion followed by ALS development Background: C9Orf72 expansions are known to be the most…
  • « Previous Page
  • 1
  • …
  • 199
  • 200
  • 201
  • 202
  • 203
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23139 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley